Managing Side Effects The transition may bring waves of side effects, with gastrointestinal issues at the helm
5,12,13 These efforts have yielded six GLP-1 RAsstarting with the development of exendin-4 (Figure 1B)-based exenatide (Figure 1C), followed by liraglutide (Figure 1D), albiglutide, dulaglutide (Figure 1E), lixisenatide, and semaglutide (Figure 1F)that have been approved by the United States Food and Drug Administration (US FDA) to treat type 2 diabetes
& Guarente, L
The reason for an even sharper pivot toward womens health
NSL literature pointer PMID 7211090 L-Carnitine laboratory index [PMID: 7211090] National Science Labs indexing note for PMID 7211090: review the PubMed methods, models, and limitations before citing
If youve been working hard to feel healthier but still struggle with stubborn weight, treatments like GLP-1 for weight loss may offer the support your body needs